Fintel reports that on October 6, 2026, Barclays upgraded their outlook for Qiagen N.V. (NYSE:QGEN) (LSE:0RLT) from Equal-Weight to Overweight. Qiagen N.V., headquartered in Venlo, the Netherlands, is ...

Following meeting with FDA, Wave plans for a single, two-year registrational trial, with a one-year interim analysis for ...

A new deep learning framework called PolyAnalysis estimates RNA poly(A) tail lengths directly from raw nanopore sequencing signals and profiles 3′-end regulation with confidence-aware analyses of p ...

This week, from life sciences to condensed matter physics and neuroscience, there was a notable shift from science that ...

Precise spatiotemporal control of protein synthesis is essential during embryogenesis, yet directly measuring translation ...

To develop gene therapy tools based on CRISPR-associated transposons (CASTs), it is essential to define how transposon ends are recognized and paired during transposition. Transposon 7 (Tn7)–like ...

A UK Biobank study of 435,078 people uses causal inference and multi-omics to map sex-specific inflammatory and lipid ...

Patent filing covers PH1 payload’s unique ability to disrupt multiple cancer-driving pathways in addition to its overall ...

Initiated a Phase 1/2 clinical trial to enroll healthy volunteers and patients with Urea Cycle Disorders of any mutational background ...

Capitalize on rising in-vitro diagnostics, NGS and biomolecule purification demand, while targeting emerging opportunities in genetic research and agricultural wastewater treatmentDublin, Oct. 01, ...

First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic ...

Introduction—To live is to maintain a flow of reactionsLast time, we introduced proteins, carbohydrates, lipids, and nucleic ...